Sami Svanbäck is an accomplished professional with extensive experience in the pharmaceutical and biotechnology sectors. As the CEO and Founding Partner of The Solubility Company since February 2018, Sami has been at the forefront of providing innovative solubility measurement services. Additionally, as a co-founder at Nanoform and an entrepreneur at Xeiron Laboratories, Sami has demonstrated a commitment to advancing research and development. Prior to these roles, Sami served as a Project Manager at the University of Helsinki, successfully leading a €550k R&D project, and held positions as a Postdoctoral Researcher and PhD Student, focusing on physicochemical characterization and miniaturization in pharmaceutical sciences. Sami's educational background includes a Ph.D. in Pharmaceutical Sciences, a Master's in Pharmaceutical Technology, and a Bachelor's in Pharmaceutical Biology, all from the University of Helsinki.
This person is not in the org chart
This person is not in any teams
This person is not in any offices